2. Conclusion
For definitive conclusions, larger numbers of patients will have to be studied, but our preliminary results indicate that (1) ATP levels decline in heart failure but not in left ventricular hypertrophy and (2) phosphocreatine/ATP ratios underestimate the true changes in myocardial high-energy phosphate concentrations in chronically injured human myocardium.
Similar content being viewed by others
References
Hardy CJ, Weiss RG, Bottomley PA, Gerstenblith G. Altered myocardial high-energy phosphate metabolites in patients with dilated cardiomyopathy. Am Heart J 1991;122:795–801.
Conway MA, Allis J, Ouwerkerk R, Niioka T, Rajagopalan B, Radda GK. Detection of low phosphocreatine to ATP ratio in failing hypertrophied human myocardium by 31P magnetic resonance spectroscopy. Lancet 1991;338:973–6.
Neubauer S, Krahe T, Schindler R, Horn M, Hillenbrand H, Entzeroth C, Mader H, Kromer EP, Riegger GA, Lackner K. et al. 31P magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease. Altered cardiac high-energy phosphate metabolism in heart failure. Circulation 1992;86:1810–8.
Neubauer S, Horn M, Pabst T, Gödde M, Lubke D, Illing B, Hahn D, Ertl G. Contributions of 31P-magneic resonance spectroscopy to the understanding of dilated heart muscle disease. Eur Heart J 1995;16(suppl O):115–8.
Neubauer S, Horn M, Cramer M, Harre K, Newell JB, Peters W, Pabst T, Ertl G, Hahn D. Ingwall JS, Kochsiek K. In patients with dilated cardiomyopathy the myocardial phosphocreatine-to-ATP ratio is a predictor of mortality. Circulation 1997;96:2190–6.
Bottomley PA, Hardy CJ, Roemer PB. Phosphate metabolite imaging and concentration measurements in human heart by nuclear magnetic resonance. Magn Reson Med 1990;14:425–34.
Bottomley PA, Atalar E, Weiss RG. Human cardiac high-energy phosphate metabolite concentrations by ID-resolved NMR spectroscopy. Magn Reson Med 1996;35:664–70.
von Kienlin M, Mejia R. Spectral localization with optimal pointspread function. Magn Reson Med 1991;94:268–87.
Meininger M, Landschütz W, Beer M, Seyfarth T, Horn M, Pabst T, Haase A, Hahn D, Neubauer S, von Kienlin M. Concentrations of human cardiac phosphorus metabolites determined by SLOOP 31P NMR spectroscopy. Magn Reson Med 1999;41:657–63.
Ingwall JS. Is cardiac failure a consequence of decreased energy reserve? Circulation 1993;87(suppl VII):58–62.
Regitz V, Fleck E. Myocardial adenine nucleotide concentrations and myocardial norepinephrine content in patients with heart failure secondary to idiopathic dilated or ischemic cardiomyopathy. Am J Cardiol 1992;69:1574–80.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Neubauer, S., Beer, M., Landschütz, W. et al. Absolute quantification of high energy phosphate metabolites in normal, hypertrophied and failing human myocardium. MAGMA 11, 73–74 (2000). https://doi.org/10.1007/BF02678501
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF02678501